Founder and CEO
Bryan is an entrepeneur with over 12 years experience in implantable neuromodulation development experience. He helped launch the Bioelectronic Medicines initiative at GlaxoSmithKline and its venture fund when he was the Engineering Director. He holds a Ph.D. in Electrical Engineering from the University of Cambridge, UK where he was a Marshall scholar.
Mark has over 20 years of entrepreneur experience with multiple startup exits. He has multiple investment exits and has worked with multiple medical device companies.
Chief Financial Officer
Kerry has over 20 years of experience in medical device companies and early stage startup financing.
Clinical Advisory Chairman
Giancarlo runs one of the largest neuromodulation practices in North America and was formerly the President of The International Neuromodulation Society.
Courtney has conducted clinical trial for over 20 years including numerous IDE and PMA trials. She had written dozens of regulatory submissions and run numerous clinical trials.